C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 471/04 (2006.01) A61K 31/245 (2006.01) A61K 31/38 (2006.01) A61K 31/395 (2006.01) A61K 31/40 (2006.01) A61K 31/415 (2006.01) A61K 31/437 (2006.01) A61K 31/4427 (2006.01) A61K 31/443 (2006.01) A61K 31/445 (2006.01) A61K 31/4453 (2006.01) A61K 31/452 (2006.01) A61K 31/454 (2006.01) A61K 31/47 (2006.01) A61K 31/55 (2006.01) C07D 209/42 (2006.01) C07D 319/18 (2006.01) C07D 405/12 (2006.01) C07D 409/12 (2006.01) C07D 411/12 (2006.01) C07D 413/04 (2006.01) C07D 413/12 (2006.01) C07D 417/12 (2006.01) C07D 455
Patent
CA 2118812
The use of a compound of formula (I) or pharmaceutically acceptable salt thereof, in which X1-(CH2)x-X2 forms a 5-7 membered ring wherain:X1 is O or S; X2 is O; S, NR or NRCO wherein R is hydrogen or C1-6alkyl; x is 1, 2 or 3; Y is O or NH; Z is sub-formula (a); (b) or (c) in the manufacture of a medicament for use in the treatment of gastrointestinal disorders, cardiovascular disorders and CNS disorders.
Baxter Gordon Smith
Gaster Laramie Mary
Kaumann Alberto Julio
Kennett Guy Anthony
King Francis David
Borden Ladner Gervais Llp
Smithkline Beecham P.l.c.
LandOfFree
5-ht4 receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 5-ht4 receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 5-ht4 receptor antagonists will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2039879